212 related articles for article (PubMed ID: 25870979)
1. Prognostic factors and survival rate of osteosarcoma: A single-institution study.
Faisham WI; Mat Saad AZ; Alsaigh LN; Nor Azman MZ; Kamarul Imran M; Biswal BM; Bhavaraju VM; Salzihan MS; Hasnan J; Ezane AM; Ariffin N; Norsarwany M; Ziyadi MG; Wan Azman WS; Halim AS; Zulmi W
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e104-e110. PubMed ID: 25870979
[TBL] [Abstract][Full Text] [Related]
2. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
3. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
5. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
6. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup.
Hauben EI; Weeden S; Pringle J; Van Marck EA; Hogendoorn PC
Eur J Cancer; 2002 Jun; 38(9):1218-25. PubMed ID: 12044509
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution.
Wang W; Yang J; Wang Y; Wang D; Han G; Jia J; Xu M; Bi W
Pathol Res Pract; 2017 Feb; 213(2):119-125. PubMed ID: 28040328
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
[TBL] [Abstract][Full Text] [Related]
9. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.
Pruksakorn D; Phanphaisarn A; Arpornchayanon O; Uttamo N; Leerapun T; Settakorn J
Cancer Epidemiol; 2015 Dec; 39(6):956-63. PubMed ID: 26540607
[TBL] [Abstract][Full Text] [Related]
10. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
Kim W; Han I; Lee JS; Cho HS; Park JW; Kim HS
J Surg Oncol; 2018 May; 117(6):1223-1231. PubMed ID: 29409122
[TBL] [Abstract][Full Text] [Related]
11. Telangiectatic osteosarcoma: a review of 87 cases.
Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
[TBL] [Abstract][Full Text] [Related]
12. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.
Ferrari S; Briccoli A; Mercuri M; Bertoni F; Picci P; Tienghi A; Del Prever AB; Fagioli F; Comandone A; Bacci G
J Clin Oncol; 2003 Feb; 21(4):710-5. PubMed ID: 12586810
[TBL] [Abstract][Full Text] [Related]
13. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
Farfalli GL; Albergo JI; Lobos PA; Smith DE; Streitenberger PD; Pallotta Rodríguez MG; Aponte-Tinao LA
Medicina (B Aires); 2015; 75(2):87-90. PubMed ID: 25919869
[TBL] [Abstract][Full Text] [Related]
14. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
15. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults.
Eleutério SJ; Senerchia AA; Almeida MT; Da Costa CM; Lustosa D; Calheiros LM; Barreto JH; Brunetto AL; Macedo CR; Petrilli AS
Pediatr Blood Cancer; 2015 Jul; 62(7):1209-13. PubMed ID: 25755160
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of osteosarcoma patients: A 15-year experience.
Yasin NF; Abdul Rashid ML; Ajit Singh V
J Orthop Surg (Hong Kong); 2020; 28(1):2309499019896662. PubMed ID: 32077796
[TBL] [Abstract][Full Text] [Related]
18. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
[TBL] [Abstract][Full Text] [Related]
19. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
20. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
